Grand Pharmaceutical Group Limited Stock OTC Markets
Stocks
CGPHF
BMG210A71016
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 17.49B 2.23B 1.92B 1.81B 1.65B 3.08B 212B 3.09B 21.42B 8.28B 108B 8.38B 8.19B 343B | P/E 2026 * |
9.7x | P/E 2027 * | 8.88x |
|---|---|---|---|---|---|
| Enterprise Value | 17.49B 2.23B 1.92B 1.81B 1.65B 3.08B 212B 3.09B 21.42B 8.28B 108B 8.38B 8.19B 343B | EV / Sales 2026 * |
1.35x | EV / Sales 2027 * | 1.24x |
| Free-Float |
34.99% | Yield 2026 * |
4.2% | Yield 2027 * | 4.6% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chao Zhou
CEO | Chief Executive Officer | 36 | 01/06/2021 |
Tin Chung Foo
SEC | Corporate Secretary | 57 | 01/09/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Tosi Wan So
BRD | Director/Board Member | 63 | 21/03/2005 |
Geng Pei
BRD | Director/Board Member | 66 | 12/05/2011 |
Ye Bi Hu
BRD | Director/Board Member | 62 | 31/12/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.21B | |
| +0.03% | -3.09% | +52.20% | +91.69% | 1,002B | |
| -0.76% | -1.52% | +49.94% | +66.34% | 649B | |
| +0.86% | -3.49% | +19.60% | +68.37% | 440B | |
| -0.80% | +0.06% | +28.73% | +35.45% | 346B | |
| -0.13% | -14.74% | +9.13% | +26.71% | 263B | |
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | |
| -0.48% | -10.69% | +39.64% | +50.82% | 213B | |
| -1.06% | -1.70% | -16.73% | -57.36% | 201B | |
| -0.68% | -2.85% | +25.69% | +91.64% | 182B | |
| Average | -0.40% | -2.06% | +22.84% | +42.34% | 393.74B | |
| Weighted average by Cap. | -0.21% | -2.39% | +32.37% | +57.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.94B 1.65B 1.42B 1.34B 1.22B 2.28B 157B 2.29B 15.85B 6.13B 80.01B 6.2B 6.06B 253B | 14.1B 1.8B 1.55B 1.46B 1.33B 2.48B 171B 2.49B 17.27B 6.67B 87.18B 6.75B 6.61B 276B |
| Net income | 1.83B 233M 200M 189M 172M 322M 22.16B 323M 2.24B 864M 11.29B 875M 856M 35.77B | 1.99B 254M 218M 206M 187M 351M 24.16B 352M 2.44B 942M 12.31B 953M 933M 38.99B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 512 Stock
- CGPHF Stock
Select your edition
All financial news and data tailored to specific country editions
